Nifty

:

22368.00

Sensex

:

73738.45

31.60 (0.14%)
650.12 (0.89%)

Login

Nifty
Sensex

:
:

22368.00
73738.45

31.60 (0.14%)
650.12 (0.89%)

Sandu Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

46/99

BSE: 524703 | NSE: Not Listed

Watchlist

NSE BSE

63.17

23-Apr-2024

Open
High
Low
Previous Close

62.89
64.00
62.00
61.92

Volume
Traded Value (lacs)
52 Week High
52 Week Low

54
6.12
85.00
49.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

61.03
51.78
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

56.79
1.19%
1.86

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.16
5.75
3.61

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.77
3.56
2.88

PAT CAGR (%)

10 Years
5 Years
3 Years

11.76
17.80
11.72

P:E (Median)

8 Years
5 Years
3 Years

42.34
48.63
48.63

P:BV (Average)

8 Years
5 Years
3 Years

1.07
2.08
2.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.18
24.05
24.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 17.43 17.09 1.99% 16.61 16.76 -0.89% 17.66 16.23 8.81% 15.27 11.42 33.71%
Expenses 16.92 16.27 4.00% 15.78 15.90 -0.75% 17.30 15.90 8.81% 14.78 10.85 36.22%
EBITDA 0.51 0.82 -37.80% 0.83 0.86 -3.49% 0.36 0.33 9.09% 0.48 0.57 -15.79%
EBIDTM 2.93% 4.79% 4.97% 5.13% 2.01% 2.02% 3.16% 5.03%
Other Income 0.03 0.03 0.00% 0.09 0.17 -47.06% 0.00 0.09 -100.00% 0.05 0.03 66.67%
Interest 0.02 0.02 0.00% 0.02 0.02 0.00% 0.02 0.02 0.00% 0.02 0.02 0.00%
Depreciation 0.14 0.13 7.69% 0.13 0.13 0.00% 0.12 0.13 -7.69% 0.13 0.13 0.00%
PBT 0.38 0.70 -45.71% 0.77 0.88 -12.50% 0.21 0.26 -19.23% 0.38 0.45 -15.56%
Tax 0.17 0.22 -22.73% 0.21 0.28 -25.00% 0.10 0.10 0.00% 0.10 0.18 -44.44%
PAT 0.21 0.48 -56.25% 0.55 0.60 -8.33% 0.11 0.17 -35.29% 0.27 0.27 0.00%
PATM 1.18% 2.83% 3.32% 3.58% 0.62% 1.04% 1.80% 2.37%
EPS 0.21 0.50 -58.00% 0.57 0.62 -8.06% 0.11 0.17 -35.29% 0.28 0.28 0.00%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 17.43 17.09 1.99% 16.61 16.76 -0.89% 17.66 16.23 8.81% 15.27 11.42 33.71%
Expenses 16.92 16.27 4.00% 15.78 15.91 -0.82% 17.30 15.90 8.81% 14.78 10.85 36.22%
EBITDA 0.51 0.82 -37.80% 0.82 0.86 -4.65% 0.36 0.33 9.09% 0.48 0.57 -15.79%
EBIDTM 2.92% 4.78% 4.97% 5.12% 2.01% 2.01% 3.16% 5.02%
Other Income 0.03 0.03 0.00% 0.09 0.17 -47.06% 0.00 0.09 -100.00% 0.05 0.03 66.67%
Interest 0.02 0.02 0.00% 0.02 0.02 0.00% 0.02 0.02 0.00% 0.02 0.02 0.00%
Depreciation 0.14 0.13 7.69% 0.13 0.13 0.00% 0.12 0.13 -7.69% 0.13 0.13 0.00%
PBT 0.38 0.70 -45.71% 0.76 0.88 -13.64% 0.21 0.26 -19.23% 0.38 0.45 -15.56%
Tax 0.17 0.22 -22.73% 0.21 0.28 -25.00% 0.10 0.10 0.00% 0.11 0.18 -38.89%
PAT 0.21 0.48 -56.25% 0.55 0.60 -8.33% 0.11 0.17 -35.29% 0.27 0.27 0.00%
PATM 1.18% 2.81% 3.31% 3.57% 0.62% 1.04% 1.78% 2.35%
EPS 0.21 0.50 -58.00% 0.57 0.62 -8.06% 0.11 0.19 -42.11% 0.28 0.31 -9.68%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 66.97 65.35 65.50 58.76 48.45 49.42 49.02 42.83 41.08 39.60 35.96 Net Sales Growth 8.89% -0.23% 11.47% 21.28% -1.96% 0.82% 14.45% 4.26% 3.74% 10.12% Cost Of Goods Sold 32.61 31.19 35.75 34.50 25.12 25.31 28.40 25.63 21.28 22.03 21.21 Gross Profit 34.36 34.16 29.76 24.26 23.33 24.11 20.62 17.19 19.79 17.58 14.76 GP Margin 51.31% 52.27% 45.44% 41.29% 48.15% 48.79% 42.06% 40.14% 48.17% 44.39% 41.05% Total Expenditure 64.78 62.86 62.63 56.60 46.91 47.33 46.55 40.97 38.21 37.17 33.87 Power & Fuel Cost - 0.39 0.34 0.33 0.33 0.33 0.32 0.23 0.40 0.51 0.55 % Of Sales - 0.60% 0.52% 0.56% 0.68% 0.67% 0.65% 0.54% 0.97% 1.29% 1.53% Employee Cost - 11.10 8.91 8.02 6.85 6.49 5.94 5.42 4.51 3.69 3.35 % Of Sales - 16.99% 13.60% 13.65% 14.14% 13.13% 12.12% 12.65% 10.98% 9.32% 9.32% Manufacturing Exp. - 3.32 3.76 3.17 2.55 2.15 1.10 0.67 0.98 0.57 0.38 % Of Sales - 5.08% 5.74% 5.39% 5.26% 4.35% 2.24% 1.56% 2.39% 1.44% 1.06% General & Admin Exp. - 6.90 5.17 3.45 4.76 4.36 4.69 4.38 4.33 3.41 3.16 % Of Sales - 10.56% 7.89% 5.87% 9.82% 8.82% 9.57% 10.23% 10.54% 8.61% 8.79% Selling & Distn. Exp. - 9.71 8.51 6.90 7.20 8.33 5.88 4.42 6.35 5.88 4.17 % Of Sales - 14.86% 12.99% 11.74% 14.86% 16.86% 12.00% 10.32% 15.46% 14.85% 11.60% Miscellaneous Exp. - 0.25 0.19 0.24 0.11 0.36 0.23 0.21 0.35 1.09 4.17 % Of Sales - 0.38% 0.29% 0.41% 0.23% 0.73% 0.47% 0.49% 0.85% 2.75% 2.95% EBITDA 2.18 2.49 2.87 2.16 1.54 2.09 2.47 1.86 2.87 2.43 2.09 EBITDA Margin 3.26% 3.81% 4.38% 3.68% 3.18% 4.23% 5.04% 4.34% 6.99% 6.14% 5.81% Other Income 0.17 0.33 0.08 0.19 0.38 0.57 0.12 0.47 0.15 0.14 0.33 Interest 0.08 0.08 0.11 0.12 0.43 1.01 1.23 1.49 1.64 1.37 1.06 Depreciation 0.52 0.52 0.53 0.56 0.55 0.64 0.60 0.87 0.69 0.57 0.54 PBT 1.74 2.22 2.32 1.68 0.92 1.02 0.76 -0.04 0.68 0.63 0.82 Tax 0.58 0.70 0.73 0.59 0.20 0.35 0.19 0.50 0.14 0.22 0.33 Tax Rate 33.33% 31.53% 31.47% 35.12% 21.74% 34.31% 25.00% 1000.00% 20.59% 34.92% 40.24% PAT 1.14 1.52 1.59 1.09 0.72 0.67 0.56 -0.44 0.54 0.41 0.50 PAT before Minority Interest 1.14 1.52 1.59 1.09 0.72 0.67 0.56 -0.44 0.54 0.41 0.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.70% 2.33% 2.43% 1.86% 1.49% 1.36% 1.14% -1.03% 1.31% 1.04% 1.39% PAT Growth -25.00% -4.40% 45.87% 51.39% 7.46% 19.64% - - 31.71% -18.00% EPS 1.18 1.57 1.64 1.12 0.74 0.69 0.58 -0.45 0.56 0.42 0.52

Description TTM Mar 23
Net Sales 66.97 65.35 Net Sales Growth 8.89% Cost Of Goods Sold 32.61 31.19 Gross Profit 34.36 34.16 GP Margin 51.31% 52.27% Total Expenditure 64.78 62.86 Power & Fuel Cost - 0.39 % Of Sales - 0.60% Employee Cost - 11.10 % Of Sales - 16.99% Manufacturing Exp. - 3.32 % Of Sales - 5.08% General & Admin Exp. - 6.91 % Of Sales - 10.57% Selling & Distn. Exp. - 9.71 % Of Sales - 14.86% Miscellaneous Exp. - 0.25 % Of Sales - 0.38% EBITDA 2.17 2.49 EBITDA Margin 3.24% 3.81% Other Income 0.17 0.33 Interest 0.08 0.08 Depreciation 0.52 0.52 PBT 1.73 2.22 Tax 0.59 0.70 Tax Rate 34.10% 31.53% PAT 1.14 1.52 PAT before Minority Interest 1.14 1.52 Minority Interest 0.00 0.00 PAT Margin 1.70% 2.33% PAT Growth -25.00% EPS 1.18 1.57

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 39.24 36.47 33.49 29.24 28.79 28.08 27.41 18.68 18.15 18.21 Share Capital 9.66 8.81 7.92 7.08 7.08 7.08 7.08 7.08 7.08 7.08 Total Reserves 29.58 27.22 24.67 22.16 21.71 21.00 20.33 11.60 11.06 11.13 Non-Current Liabilities 1.04 0.94 0.95 0.85 0.99 1.06 0.89 1.71 2.20 2.64 Secured Loans 0.00 0.00 0.00 0.00 0.18 0.25 0.09 0.78 1.19 1.71 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 13.88 11.87 12.52 11.33 13.86 15.38 18.14 21.02 21.17 16.02 Trade Payables 8.40 6.82 6.67 5.76 4.23 3.02 4.09 5.88 6.24 4.46 Other Current Liabilities 1.41 1.08 1.10 1.15 1.12 1.15 1.48 1.90 2.16 2.00 Short Term Borrowings 0.00 0.00 0.02 1.25 5.93 9.11 9.93 10.05 10.68 7.60 Short Term Provisions 4.07 3.98 4.73 3.18 2.58 2.11 2.64 3.19 2.09 1.96 Total Liabilities 54.16 49.28 46.96 41.42 43.64 44.52 46.44 41.41 41.52 36.87 Net Block 16.62 16.00 16.17 16.60 17.04 17.57 17.49 7.81 8.36 9.09 Gross Block 27.51 26.38 26.02 25.89 25.78 25.67 25.13 14.50 14.36 14.04 Accumulated Depreciation 10.89 10.37 9.84 9.29 8.73 8.10 7.64 6.69 6.00 4.95 Non Current Assets 28.63 25.64 16.42 18.99 23.56 23.69 18.48 8.55 9.05 9.78 Capital Work in Progress 0.42 0.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 9.66 9.11 0.24 0.82 1.13 1.12 0.99 0.73 0.70 0.69 Long Term Loans & Adv. 0.00 0.00 0.00 1.32 5.10 5.00 0.00 0.00 0.00 0.00 Other Non Current Assets 1.94 0.05 0.00 0.25 0.28 0.00 0.00 0.00 0.00 0.00 Current Assets 25.54 23.65 30.54 22.42 20.08 20.83 27.95 32.86 32.46 27.09 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 14.33 11.27 11.14 14.36 13.26 11.44 10.68 12.04 12.68 13.57 Sundry Debtors 4.79 3.99 5.35 4.68 4.80 6.69 6.35 7.15 6.56 5.90 Cash & Bank 2.29 4.17 11.66 1.54 0.79 1.41 2.69 0.69 4.13 1.46 Other Current Assets 4.13 0.67 0.31 0.10 1.24 1.29 8.24 12.98 9.09 6.16 Short Term Loans & Adv. 3.74 3.55 2.10 1.74 1.17 1.24 8.20 12.93 9.05 6.14 Net Current Assets 11.66 11.77 18.02 11.09 6.22 5.45 9.81 11.84 11.29 11.07 Total Assets 54.17 49.29 46.96 41.41 43.64 44.52 46.43 41.41 41.51 36.87

Description Mar 23
Shareholder's Funds 39.24 Share Capital 9.66 Total Reserves 29.58 Non-Current Liabilities 1.04 Secured Loans 0.00 Unsecured Loans 0.00 Long Term Provisions 0.00 Current Liabilities 13.88 Trade Payables 8.40 Other Current Liabilities 1.41 Short Term Borrowings 0.00 Short Term Provisions 4.08 Total Liabilities 54.16 Net Block 16.62 Gross Block 27.51 Accumulated Depreciation 10.89 Non Current Assets 28.62 Capital Work in Progress 0.42 Non Current Investment 9.65 Long Term Loans & Adv. 0.00 Other Non Current Assets 1.94 Current Assets 25.55 Current Investments 0.00 Inventories 14.33 Sundry Debtors 4.79 Cash & Bank 2.30 Other Current Assets 4.13 Short Term Loans & Adv. 3.74 Net Current Assets 11.66 Total Assets 54.17

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 0.22 0.95 7.59 6.20 3.74 1.23 4.91 -1.43 4.75 -1.06 PBT 2.22 2.32 1.68 0.92 1.02 0.76 -0.04 0.68 0.63 0.82 Adjustment 0.48 0.63 0.62 0.96 1.69 1.81 2.35 2.19 2.29 1.26 Changes in Working Capital -1.78 -1.13 5.75 4.47 1.35 -1.01 1.30 -4.08 1.96 -2.91 Cash after chg. in Working capital 0.92 1.83 8.05 6.34 4.05 1.56 3.62 -1.21 4.88 -0.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.70 -0.88 -0.46 -0.14 -0.31 -0.32 1.30 -0.22 -0.13 -0.24 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.53 -5.47 -5.58 -0.37 -0.10 -0.62 -0.59 0.05 -0.18 -0.70 Net Fixed Assets -1.07 -0.84 -0.13 -0.11 -0.11 -0.54 -10.63 -0.14 -0.32 -1.02 Net Investments -0.55 -8.87 0.58 0.31 -0.01 -0.13 -0.26 -0.03 -0.01 -0.02 Others 2.15 4.24 -6.03 -0.57 0.02 0.05 10.30 0.22 0.15 0.34 Cash from Financing Activity 0.58 0.93 1.30 -5.36 -4.26 -1.89 -2.33 -2.06 -1.90 -0.25 Net Cash Inflow / Outflow 1.33 -3.59 3.31 0.48 -0.62 -1.28 1.99 -3.44 2.67 -2.01 Opening Cash & Equivalents 0.94 4.53 1.22 0.74 1.41 2.69 0.69 4.13 1.46 3.47 Closing Cash & Equivalent 2.27 0.94 4.53 1.22 0.79 1.41 2.69 0.69 4.13 1.46

Description Mar 23
Cash From Operating Activity 0.22 PBT 2.22 Adjustment 0.48 Changes in Working Capital -1.77 Cash after chg. in Working capital 0.92 Interest Paid 0.00 Tax Paid -0.70 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity 0.54 Net Fixed Assets Net Investments Others Cash from Financing Activity 0.58 Net Cash Inflow / Outflow 1.34 Opening Cash & Equivalents 0.94 Closing Cash & Equivalent 2.28

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 31.47 30.71 29.63 28.22 27.39 26.20 25.05 26.39 25.63 25.72 ROA 2.95% 3.30% 2.47% 1.69% 1.52% 1.23% -1.01% 1.30% 1.06% 1.41% ROE 5.30% 6.29% 5.03% 3.66% 3.53% 3.09% -2.44% 2.92% 2.28% 2.76% ROCE 7.94% 9.35% 7.87% 5.79% 7.58% 7.06% 5.30% 7.65% 6.80% 6.93% Fixed Asset Turnover 2.43 2.50 2.67 1.88 1.92 1.94 2.20 3.24 2.82 2.96 Receivable days 24.53 26.02 26.43 35.70 42.42 48.41 56.39 53.44 56.68 53.20 Inventory Days 71.49 62.44 67.19 104.04 91.19 82.11 94.93 96.36 119.43 117.65 Payable days 89.03 68.87 65.75 72.61 29.71 29.95 47.48 62.48 63.82 45.59 Cash Conversion Cycle 6.99 19.59 27.87 67.12 103.90 100.57 103.84 87.31 112.29 125.26 Total Debt/Equity 0.00 0.00 0.00 0.06 0.32 0.51 0.59 0.61 0.69 0.55 Interest Cover 28.89 22.06 15.62 3.11 2.01 1.61 1.04 1.41 1.46 1.78

Description Mar 23
Book Value (Rs.) 31.47 ROA 2.81% ROE 5.00% ROCE 7.55% Fixed Asset Turnover 2.38 Receivable days 26.77 Inventory Days 80.01 Payable days 98.27 Cash Conversion Cycle 8.51 Total Debt/Equity 0.00 Interest Cover 28.85

Top Investors:

sanmark realty and finance private limited

neelamber leasing and finvest private limited

sanbro marketing services pvt ltd

tanvi jignesh mehta

noumura realty and constructions private limited

phybrichem engineers private limited

hitesh kuvelkar

trans scan securities private limited

Annual Reports:

News Update:

Sandu Pharmaceutical - Quarterly Results
14th Feb 2024, 21:04 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback